Hematology Program

At the Yale Hematology Program, services for the diagnosis and treatment of blood cancers offer the most comprehensive and advanced options in the region. Our services are designed to meet patients' physical, emotional and psychological needs. Physicians within the program are organized into a multispecialty team that discusses the treatment plans for patients until consensus is reached on the best management course for each individual patient.  Our researchers continue to work on current promising therapies and are able to offer treatment for all phases and stages of lymphoma, leukemia, and myeloma - early, late and refractory.

Yale has an expert hematopathology diagnostic team capable of pathologic review of lymph nodes and bone marrow with in-depth molecular and cytogenetic analysis. Every diagnostic technique is available at Yale including: bone marrow examination, bone imaging, M protein analysis, cytogenetics, immunophenotyping, and FISH and PCR analysis. Diagnostic analysis also includes relevant genetic testing and the identification of markers of prognosis. The Yale Cancer Center maintains a tissue bank used for novel research studies in cancer treatment and prevention.

Treatment approaches for blood cancers may include chemotherapy, radiation oncology, stem cell or marrow transplantation, or immunotherapy.
Patients benefit from specialized resources at Yale-New Haven Hospital, such as the state-of-the-art nuclear imaging technology, one of the largest total skin electron beam radiation oncology program worldwide, 3D conformal radiotherapy, intensity modulated radiation therapy (IMRT) and stereotactic radiosurgery at the Yale-New Haven Gamma Knife Center.

Cutaneous Lymphoma
Yale Cancer Center continues to make innovative advances in the diagnosis and treatment of cutaneous lymphoma through the focused efforts of a ground-breaking clinical research team.  Their multispecialty approach to the treatment of patients with cutaneous lymphomas has led to the development of FDA approved treatments that are now the standard of care worldwide.  Transimmunization, an innovation related to extracorporeal photochemotherapy (ECP) which was the first FDA approved selective immunotherapy for any cancer, is currently being investigated in clinical trials at Yale Cancer Center.  As the scientific and clinical successor of extracorporeal photochemotherapy, it has potential to replace ECP as the standard of care for patients with advanced forms of cutaneous T-cell lymphoma. 

Hematology
Yale's hematologists play a unique role as a regional resource for difficult and challenging cases, with a large number of referrals coming from other hematologists and oncologists in the physician community throughout Connecticut and New England. They work closely with the physicians in the Bone Marrow Transplant service, both to provide primary care to patients referred for transplant that are deemed to be better served by non-transplant modalities, and to provide rapid referral of those patients who are candidates for stem cell transplant.

Bone Marrow Transplant
Bone marrow transplants and autologous transplants have been performed at Yale since 1988. Led by Dennis Cooper, MD, the Allogeneic Bone Marrow and Stem Cell Transplantation program at the Yale Cancer Center was one of the first cancer centers to use the procedure to successfully treat cancer patients. New clinical trials are available for patients who have not been successfully matched with a donor and are at high risk for relapse.

	Baehring, Joachim M, MD	Associate Professor of Neurology, of Medicine (Medical Oncology) and of Neurosurgery; Clinical Program Leader, Brain Tumor Program, Smilow Cancer Hospital	(203) 785-7284 Appts (203) 737-2591 Fax
	Braddock, Demetrios, MD, PhD	Associate Professor of Pathology	(203) 785-6828 Appts (203) 785-6899 Fax
	Braverman, Irwin Merton, MD	Professor Emeritus of and Senior Research Scientist in Dermatology	(203) 789-1249 Appts (203) 776-6188 Fax
	Cheng, David W., MD, PhD	Associate Professor of Diagnostic Radiology; Chief, Nuclear Medicine; Director, Nuclear Medicine Fellowship Program; Co-Medical Director, Yale University PET Center	(203) 200-5610 Appts
	Cooper, Dennis L., MD	Professor of Medicine (Hematology)	(203) 200-4363 Appts (203) 200-6385 Fax
	Dhodapkar, Madhav V., MBBS	Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Clinical Research Program Leader, Hematology Program, Yale Cancer Center	(203) 200-4363 Appts (203) 200-6385 Fax
	Duffy, Thomas Patrick, MD	Professor of Medicine (Hematology)	(203) 200-4363 Appts (203) 200-6385 Fax
	Edelson, Richard L, MD	Aaron B. and Marguerite R. Lerner Professor of Dermatology; Chair and Professor, Department of Dermatology, Yale School of Medicine	(203) 789-1249 Appts (203) 776-6188 Fax
	Foss, Francine M, MD	Professor of Medicine (Hematology) and of Dermatology	(203) 200-4363 Appts (203) 200-6385 Fax
	Girardi, Michael, MD, FAAD	Professor of Dermatology; Director, Residency Program	(203) 789-1249 Appts
	Halene, Stephanie, MD, PhD	Assistant Professor of Medicine (Hematology)	(203) 200-4363 Appts (203) 785-7232 Fax
	Isufi, Iris, MD	Assistant Professor of Medicine (Hematology)	(203) 200-4363 Appts (203) 200-6385 Fax
	Kadan-Lottick, Nina, MD	Associate Professor of Pediatrics (Hematology / Oncology); Medical Director, HEROS Program	(203) 785-4081 Appts (203) 737-2228 Fax
	Lee, Alfred Ian, MD, PhD	Assistant Professor of Medicine (Hematology); Associate Firm Chief, Smilow-11, Yale Cancer Center; Assistant Program Director, Traditional Internal Medicine Residency Program	(203) 200-4363 Appts (203) 200-2360 Fax
	McPhedran, Peter, MD	Professor Emeritus of Laboratory Medicine; Associate Research Scientist, Internal Medicine	(203) 200-4363 Appts (203) 200-6385 Fax
	Parker, Terri Lynn, MD	Assistant Professor of Medicine (Hematology); Assistant Professor	(203) 200-4363 Appts (203) 200-6385 Fax
	Persky, Daniel O., MD	Assistant Professor of Medicine (Hematology)
	Podoltsev, Nikolai Alexandrovich, MD, PhD	Assistant Professor of Medicine (Hematology); Associate Director of the Hematology/Oncology Fellowship Program	(203) 200-4363 Appts (203) 200-6385 Fax
	Roberts, John David, MD	Director, Adult Sickle Cell Program at Yale-New Haven Hospital
	Roberts, Kenneth B, MD	Associate Professor of Therapeutic Radiology; Medical Director, Yale-New Haven Shoreline Medical Center, Department of Radiation Oncology; Associate Chief and Medical Director for Radiation Oncology at Shoreline Medical Center, Yale-New Haven Hospital	(203) 200-2000 Appts (203) 200-2001 Fax
	Seropian, Stuart Evan, MD	Associate Professor of Medicine (Hematology)	(203) 200-4363 Appts (203) 200-6385 Fax
	Shlomchik, Warren D, MD	Associate Professor of Medicine (Hematology), of Immunobiology and of Medicine (Hematology)	(203) 200-4363 Appts (203) 737-2617 Fax
	Sklar, Jeffrey L., MD, PhD	Professor of Pathology and of Laboratory Medicine; Director, Molecular Diagnostics Program; Director, Molecular Genetics Pathology Fellowship; Director, Molecular Tumor Profiling Laboratory; Director of Molecular and Genomic Pathology	(203) 737-6012 Appts (203) 785-6899 Fax
	Solomon, Lawrence, MD	Associate Professor of Medicine (Medical Oncology and Hematology); Staff Physician, Palliative and End-of-Life Care Education	(203) 200-4780 Appts (203) 785-3712 Fax
	Strout, Matthew, MD, PhD	Assistant Professor of Medicine (Hematology)	(203) 200-4363 Appts
	Wilson, Lynn D., MD, MPH, FASTRO	Professor of Therapeutic Radiology and of Dermatology; Vice Chairman, Therapeutic Radiology; Clinical Director, Therapeutic Radiology; Residency Training Program Director, Therapeutic Radiology; Clinical Program Leader, Therapeutic Radiology, Yale Cancer Center	(203) 200-2000 Appts (203) 688-3501 Fax

More Info...